Cannabidiol (CBD) is a non-psychoactive compound derived from cannabis, lacking the tetrahydrocannabinol (THC) that gives marijuana users a carefree high.
CBD has become wildly popular for recreational purposes — it is inhaled through vapor pens, taken in capsules, and mixed with teas and fruity drinks, mainly as a relaxant. Several preliminary clinical studies even claim it can treat a range of health conditions, such as anxiety and epilepsy.
Scientists at Complutense Univ. (UCM) in Madrid are using CBD to help nanoparticles pass through the blood-brain barrier (BBB), a monolayer of endothelial cells that is extremely efficient at blocking the passage of foreign substances into the brain.
Would you like to access the complete CEP News Update?
No problem. You just have to complete the following steps.
You have completed 0 of 2 steps.
-
Log in
You must be logged in to view this content. Log in now.
-
AIChE Membership
You must be an AIChE member to view this article. Join now.
Copyright Permissions
Would you like to reuse content from CEP Magazine? It’s easy to request permission to reuse content. Simply click here to connect instantly to licensing services, where you can choose from a list of options regarding how you would like to reuse the desired content and complete the transaction.
